InvestorsHub Logo
Followers 141
Posts 4459
Boards Moderated 0
Alias Born 03/16/2009

Re: None

Friday, 01/18/2019 12:29:25 PM

Friday, January 18, 2019 12:29:25 PM

Post# of 75812
I looked at the LinkedIn message Doctor Dalton posted, and I must admit it does sound encouraging. I also reviewed the press release put out by MariMed, and I suspect any reasonable individual would have to admit that it does fit nicely with what Doctor Dalton says he is doing. Like others, I too would like to see the promised financials, but I think we have to consider what would likely be in those financials that should not be disclosed until everything is signed and sealed.

The first thing that comes to mind is the partnership to develop the Univec cannabis transdermal patch would have to be described along with the potential target market. Both these topics are material information, and they would need to be described and explained. In addition, any payment either to Dalton or from Dalton to other business entities would also have to be listed. The problem with these disclosures (which currently are not necessary for a non-reporting company) is that they could reveal information that might jeopardize current plans and negotiations. Frustrating to say the least, but understandable.

Like everyone else, I sure would like to see more information, but our only recourse is to buy or sell based on our own research and convictions.

Meanwhile, if Dalton is successful, the potential gains for even small time penny stock investors is astronomical. The choice is yours.